New hope for Hard-to-Treat cancers? early trial launches
Disease control
Recruiting now
This early-phase study tests a new drug called DR-0202 in people with advanced solid tumors (like breast, lung, or pancreatic cancer) that have not responded to at least two prior treatments. The main goals are to check the drug's safety and find the best dose. About 96 participa…
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated Apr 29, 2026 00:51 UTC